| 名稱 | ESR1 p.Y537S Reference Standard |
| 型號(hào) | CBP10603 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | ESR1 p.Y537S Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 新型冠狀病毒：用于診斷的假病毒標(biāo)準(zhǔn)品和用于藥物研發(fā)的假病毒模型
- IL9細(xì)胞篩選模型
- 為什么STR鑒定對(duì)于ATCC細(xì)胞系來說很重要
- TSHR細(xì)胞模型簡(jiǎn)介
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 【靶點(diǎn)模型+診斷質(zhì)控】c-Kit常見突變的藥物開發(fā)和診斷
- 人類健康和疾病的新興參與者——RXFP1
- 3年回顧，賀教授敲錯(cuò)了基因？CXCR4 or CCR5
- FGFR3-TACC3融合藥物細(xì)胞篩選模型
- 購買細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10603ESR1 p.Y537S Reference Standard
- 詳細(xì)內(nèi)容
CBP10603 | |
| Format | Genomic DNA |
| Description | ESR1, estrogen receptor alpha, modulates response to estrogen and is used as a marker to predict response to endocrine therapy in breast cancer patients. ESR1 fusions are recurrent in breast cancer, and mutations in ESR1 have been associated with decreased response to endocrine therapy in breast cancer. |
| Technical Data | |
| DNA Change | c.1610A>C |
| AA Change | p.Y537S |
| Mutation type | N/A |
| Zygosity | N/A |
| Allelic Frequency | N/A |
| Transcript | N/A |
| Cosmic ID | COSM1074639 |
| Chr position(GRCh37) | N/A |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)